by The Cell Culture Market is estimated to be valued at US$ 10.89 Bn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Cell culture refers to the process by which cells are grown under controlled conditions, generally outside their natural environment. It involves the development or use of cell lines to be studied and grown in an artificial environment that enables them to survive and grow. Cell culture is an important biomedical tool used extensively in basic research, applied research, and industrial applications such as drug discovery, drug toxicity testing, and biopharmaceutical manufacturing. Various types of cells cultured include stem cells, primary cell cultures, and cell lines. Products used in cell culture include media, reagents, dishes, and equipment such as bioreactors, incubators, bottles, and flasks.
Market Dynamics:
Increasing demand for regenerative medicine is expected to be a major driver for the cell culture market growth over the forecast period. Regenerative medicine utilizes stem cells and tissue engineering techniques for repairing damaged tissues and treating chronic diseases. Cell culture provides an effective tool for expanding stem cells and growing tissues required for regenerative therapy applications. The increasing R&D funding and initiatives by pharmaceutical companies and research institutes to boost cell culture-based vaccine development is also fueling market growth. However, the high cost of cell biology research equipment and reagents may hamper market growth over the forecast period.
Segment Analysis
The cell culture market can be segmented into consumables and equipment. Within consumables, the media sub-segment dominates as it accounts for the largest share due to wide applications of cell culture media in bioproduction, tissue engineering, and others. Media provides key nutrients to maintain and support cell growth outside their natural environment in vitro.
PEST Analysis
Political: The government’s support for research and funding in cell-based applications, regenerative medicine, and stem cell research has created a positive environment for Cell Culture Market growth.
Economic: Increased investments by pharmaceutical and biotechnology companies in R&D for drug discovery using cell culture techniques is fueling market expansion.
Social: Rising incidence of chronic diseases and growing demand for advanced therapeutic treatments are buttressing demand for cell culture procedures in clinical research.
Technological: Advancements in microcarrier-based 3D cell culture technology, suspension cell culture systems, and development of serum-free and chemically defined media are broadening applications of cell culture.
Key Takeaways
The global cell culture market size is expected to reach US$ 20.89 Billion By 2030, expanding at a CAGR of 7.2% during the forecast period. Increasing investment in stem cell research and regenerative medicine by both government as well as private organizations is anticipated to drive the market.
North America dominates the cell culture market owing to significant government funding for cell-based research, presence of global market leaders, and availability of infrastructure and skilled professionals. The rising burden of cancer and other chronic illnesses in the region is also propelling regional market growth.
Key players operating in the cell culture market are Corning Incorporated, Merck KGaA, Sartorius AG, BioSpherix, Ltd., Cell Culture Company, LLC, Thermo Fisher Scientific Inc., VWR International LLC, and Lonza. Corning Incorporated holds the leading market position on account of its extensive product portfolio of cell culture consumables like media, sera, and reagents.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
